Action Alterity Therapeutics (PK) - PRNAF

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

0,0036

Prix Achat

0,0001

Prix Vente

0,2649

Volume échangé

0,00 Fourchette du Jour 0,00

0,0002 Plage de 52 semaines 0,0068

Cap du marché

8,699M

Clôture Veille

0,0036

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

Actions en circulation

2 416 418 418

Rendement du Dividende

Ratio Cours sur Bénéfices

-1,27

Bénéfice par action (BPA)

-0,01

Chiffre d'affairess

4,02M

Bénéfice net

-19,12M

Alterity Therapeutics Limited creates an alternate, healthier life for people living with neurodegenerative diseases. Alterity Therapeutics Limited creates an alternate, healthier life for people living with neurodegenerative diseases.

Secteur

Biological Pds,ex Diagnstics

Industrie

Health Care Diversified

Site Web

www.alteritytherapeutics.com

Siège social

Melbourne, Victoria, Aus

Fondé

1997

Alterity Therapeutics Ltd (PK) est coté dans le secteur Biological Pds,ex Diagnstics de la OTCMarkets avec le ticker PRNAF. Le dernier cours de clôture d'Alterity Therapeutics (PK) était de US$0,00. Au cours de la dernière année, les actions de Alterity Therapeutics (PK) ont été négociées dans une fourchette de prix de US$ 0,0002 à US$ 0,0068.

Alterity Therapeutics (PK) compte actuellement 2 416 418 418 actions en circulation. La capitalisation boursière d'Alterity Therapeutics (PK) est de US$8,70 million. Alterity Therapeutics (PK) a un ratio cours/bénéfice (ratio PE) de -1.27.

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	-0.0032	-47.0588235294	0.0068	0.0068	0.0036	4500	0.00502222	CS
52	0.0016	80	0.002	0.0068	0.0002	2440	0.00401156	CS
156	-0.0104	-74.2857142857	0.014	0.0473	0.0002	17261	0.01153813	CS
260	-0.0099	-73.3333333333	0.0135	0.0653	0.0001	62363	0.02214047	CS

PRNAF - Frequently Asked Questions (FAQ)

What is the current Alterity Therapeutics (PK) share price?

The current share price of Alterity Therapeutics (PK) is US$ 0,0036

How many Alterity Therapeutics (PK) shares are in issue?

Alterity Therapeutics (PK) has 2 416 418 418 shares in issue

What is the market cap of Alterity Therapeutics (PK)?

The market capitalisation of Alterity Therapeutics (PK) is USD 8,7M

What is the 1 year trading range for Alterity Therapeutics (PK) share price?

Alterity Therapeutics (PK) has traded in the range of US$ 0,0002 to US$ 0,0068 during the past year

What is the PE ratio of Alterity Therapeutics (PK)?

The price to earnings ratio of Alterity Therapeutics (PK) is -1,27

What is the cash to sales ratio of Alterity Therapeutics (PK)?

The cash to sales ratio of Alterity Therapeutics (PK) is 5,88

What is the reporting currency for Alterity Therapeutics (PK)?

Alterity Therapeutics (PK) reports financial results in AUD

What is the latest annual turnover for Alterity Therapeutics (PK)?

The latest annual turnover of Alterity Therapeutics (PK) is AUD 4,02M

What is the latest annual profit for Alterity Therapeutics (PK)?

The latest annual profit of Alterity Therapeutics (PK) is AUD -19,12M

What is the registered address of Alterity Therapeutics (PK)?

The registered address for Alterity Therapeutics (PK) is LEVEL 3, 62 LYGON STREET, CARLTON, MELBOURNE, VICTORIA, 3053

What is the Alterity Therapeutics (PK) website address?

The website address for Alterity Therapeutics (PK) is www.alteritytherapeutics.com

Which industry sector does Alterity Therapeutics (PK) operate in?

Alterity Therapeutics (PK) operates in the HEALTH CARE DIVERSIFIED sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
ELIQQElectriq Power Holdings Inc (CE)	US$ 0,10 (99 900,00%)	100
GNTLFGenetic Technologies Ltd (PK)	US$ 1,00 (90 809,09%)	100
VIVEViveve Medical Inc (CE)	US$ 0,0003 (29 900,00%)	7,33k
BTIMBoatim Inc (CE)	US$ 0,0002 (19 900,00%)	799
CLVRClever Leaves Holdings Inc (CE)	US$ 0,0002 (19 900,00%)	592
RAASYCloopen Group Holding Limited (CE)	US$ 0,000001 (-100,00%)	214
EWGFFEat Well Investment Group Inc (CE)	US$ 0,000001 (-100,00%)	47,01k
SOLBFSoLVBL Solutions Inc (CE)	US$ 0,000001 (-99,99%)	10k
HAVLFHavn Life Sciences Inc (CE)	US$ 0,000001 (-99,98%)	4,02k
ENDRFEndor AG (GM)	US$ 0,0001 (-99,98%)	560
HMBLHUMBL Inc (PK)	US$ 0,00095 (5,56%)	344,89M
PHILPHI Group Inc (PK)	US$ 0,0003 (0,00%)	312,21M
PLPLPlandai Biotechnology Inc (PK)	US$ 0,0001 (0,00%)	215,71M
RDARRaadr Inc (PK)	US$ 0,0014 (16,67%)	174,96M
CHNVFChina Youzan Ltd (PK)	US$ 0,0177 (10,63%)	100M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Alterity Therapeutics Ltd (PK) (PRNAF)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Alterity Therapeutics Ltd (PK)

PRNAF Dernières nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PRNAF - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Alterity Therapeutics Ltd (PK) (PRNAF) Cours

Alterity Therapeutics Ltd (PK) (PRNAF)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Alterity Therapeutics Ltd (PK)

PRNAF Dernières nouvelles

PRNAF - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application